Targeting Angiogenesis in Rheumatoid Arthritis

Author(s): Zoltan Szekanecz, Alisa E. Koch

Journal Name: Current Rheumatology Reviews

Volume 4 , Issue 4 , 2008

Become EABM
Become Reviewer


Angiogenesis, the development of new capillaries, is a crucial process in health and disease. The perpetuation of neovascularization in rheumatoid arthritis is highly involved in leukocyte extravasation into the synovium and pannus formation. Numerous soluble and cell surface-bound angiogenic mediators, including growth factors, cytokines, proteases, matrix macromolecules, cell adhesion receptors, chemokines and chemokine receptors, have been implicated in the process of neovascularization. Endogenous angiostatic factors, primarily angiostatin, endostatin, IL-4, IL-13, some angiostatic chemokines may be used to downregulate neovascularization. In addition, angiogenesis might be targeted by several specific approaches against VEGF, angiopoietin, αVβ3 integrin or by exogenously administered compounds including DMARDs, anti-TNF agents, fumagillin analogues or thalidomide. Potentially all anti-angiogenic could be tried in order to control synovitis.

Keywords: Angiogenesis, rheumatoid arthritis, targeting, angiogenic mediators, angiostasis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [298 - 303]
Pages: 6
DOI: 10.2174/157339708786263942
Price: $65

Article Metrics

PDF: 3